H Zhang1, R P Kandel, H K Atakari, D Dean. 1. University of California School of Medicine, Children,s Hospital Oakland Research Institute, Oakland, CA 94609, USA.
Abstract
BACKGROUND: Recently, a significant association between Chlamydia trachomatis infection and postoperative trachomatous trichiasis (TT) recurrence was shown. The current study evaluated whether azithromycin treatment at the time of surgery could reduce recurrence. METHODS: As part of Nepal's national trachoma control programme, patients received azithromycin (53 patients) orplacebo (56 patients) at surgery. Conjunctivae were graded for trachoma and swabbed to detect chlamydiae preoperatively and postoperatively up to 12 months. Logistic regression was performed for associations of treatment option with recurrence, infection, and active trachoma (by eye and by patient). RESULTS:TT recurrence was 28.9% at 12 months. Recurrence was significantly lower for those with major TT at baseline in the azithromycin group at 12 months (p = 0.03); incident recurrence was also significantly lower at 6 months (OR, 0.056; 95% CI, 0 to 0.423; p = 0.004). There was a trend for increased recurrence among those with minor TT at baseline and for reduction of active trachoma and infection in the azithromycin group but not the placebo group. CONCLUSION: These data suggest that azithromycin treatment at the time of surgery may be warranted for patients with major TT. However, treatment should be investigated further for minor TT, for efficacy at subsequent time intervals and in other trachoma endemic settings.
RCT Entities:
BACKGROUND: Recently, a significant association between Chlamydia trachomatis infection and postoperative trachomatous trichiasis (TT) recurrence was shown. The current study evaluated whether azithromycin treatment at the time of surgery could reduce recurrence. METHODS: As part of Nepal's national trachoma control programme, patients received azithromycin (53 patients) or placebo (56 patients) at surgery. Conjunctivae were graded for trachoma and swabbed to detect chlamydiae preoperatively and postoperatively up to 12 months. Logistic regression was performed for associations of treatment option with recurrence, infection, and active trachoma (by eye and by patient). RESULTS:TT recurrence was 28.9% at 12 months. Recurrence was significantly lower for those with major TT at baseline in the azithromycin group at 12 months (p = 0.03); incident recurrence was also significantly lower at 6 months (OR, 0.056; 95% CI, 0 to 0.423; p = 0.004). There was a trend for increased recurrence among those with minor TT at baseline and for reduction of active trachoma and infection in the azithromycin group but not the placebo group. CONCLUSION: These data suggest that azithromycin treatment at the time of surgery may be warranted for patients with major TT. However, treatment should be investigated further for minor TT, for efficacy at subsequent time intervals and in other trachoma endemic settings.
Authors: R J Bowman; O S Soma; N Alexander; P Milligan; J Rowley; H Faal; A Foster; R L Bailey; G J Johnson Journal: Trop Med Int Health Date: 2000-08 Impact factor: 2.622
Authors: D L Bain; T Lietman; S Rasmussen; S Kalman; J Fan; C Lammel; J Z Zhang; C R Dawson; J Schachter; R S Stephens Journal: J Infect Dis Date: 2001-12-03 Impact factor: 5.226
Authors: J Schachter; S K West; D Mabey; C R Dawson; L Bobo; R Bailey; S Vitale; T C Quinn; A Sheta; S Sallam; H Mkocha; D Mabey; H Faal Journal: Lancet Date: 1999-08-21 Impact factor: 79.321
Authors: Anthony W Solomon; Martin J Holland; Matthew J Burton; Sheila K West; Neal D E Alexander; Aura Aguirre; Patrick A Massae; Harran Mkocha; Beatriz Muñoz; Gordon J Johnson; Rosanna W Peeling; Robin L Bailey; Allen Foster; David C W Mabey Journal: Lancet Date: 2003-07-19 Impact factor: 79.321
Authors: Victor H Hu; Patrick Massae; Helen A Weiss; Caroline Chevallier; Jecinta J Onyango; Isaac A Afwamba; David C W Mabey; Robin L Bailey; Matthew J Burton Journal: Invest Ophthalmol Vis Sci Date: 2011-04-06 Impact factor: 4.799
Authors: Saul N Rajak; Pateh Makalo; Ansumana Sillah; Martin J Holland; David C W Mabey; Robin L Bailey; Matthew J Burton Journal: Invest Ophthalmol Vis Sci Date: 2010-05-26 Impact factor: 4.799
Authors: Emily W Gower; Shannath L Merbs; Beatriz E Munoz; Amir Bedri Kello; Wondu Alemayehu; Alemush Imeru; Sheila K West Journal: Invest Ophthalmol Vis Sci Date: 2011-04-25 Impact factor: 4.799
Authors: Emily W Gower; Sheila K West; Sandra D Cassard; Beatriz E Munoz; Jennifer C Harding; Shannath L Merbs Journal: PLoS Negl Trop Dis Date: 2012-06-26
Authors: Saul N Rajak; Esmael Habtamu; Helen A Weiss; Amir B Kello; Bayeh Abera; Mulat Zerihun; Teshome Gebre; Clare E Gilbert; Peng T Khaw; Paul M Emerson; Matthew J Burton Journal: PLoS Negl Trop Dis Date: 2013-08-22
Authors: Saul N Rajak; Esmael Habtamu; Helen A Weiss; Amir Bedri Kello; Teshome Gebre; Asrat Genet; Robin L Bailey; David C W Mabey; Peng T Khaw; Clare E Gilbert; Paul M Emerson; Matthew J Burton Journal: PLoS Med Date: 2011-12-13 Impact factor: 11.069
Authors: Matthew J Burton; Saul N Rajak; Athumani Ramadhani; Helen A Weiss; Esmael Habtamu; Bayeh Abera; Baye Abera; Paul M Emerson; Peng T Khaw; David C W Mabey; Martin J Holland; Robin L Bailey Journal: PLoS Negl Trop Dis Date: 2012-12-20